Taken together, PPARα deficiency leads to lower mitochondria numbers, defective FA oxidative metabolism, and aberrant mitochondria functions which collectively contribute to the development of liver steatosis and hypoketonemia in Ppara-/- neonates as a result of their inability to metabolize milk lipids. The gene discussed is PPARA; the disease is fatty liver disease.